Trump’s tariff rollout leaves many questions for drugmakersnews2025-04-03T00:08:58+00:00April 3rd, 2025|Endpoints News|
Trump’s tariffs could leave the pharma industry scramblingnews2025-04-02T20:48:38+00:00April 2nd, 2025|Endpoints News|
Biopharma execs rethink Trump impact after FDA cutsnews2025-04-02T19:47:10+00:00April 2nd, 2025|Endpoints News|
New FDA Commissioner Marty Makary addresses staff a day after firingsnews2025-04-02T18:21:25+00:00April 2nd, 2025|Endpoints News|
Eli Lilly adds obesity startup knownwell to its direct-to-consumer servicenews2025-04-02T16:55:45+00:00April 2nd, 2025|Endpoints News|
BIO CEO on tariffs, MAHA and the future of the biotech industrynews2025-04-02T15:49:36+00:00April 2nd, 2025|Endpoints News|
Tang Capital’s Concentra nabs a win, making a deal to buy Allakosnews2025-04-02T14:52:14+00:00April 2nd, 2025|Endpoints News|
US regulatory chief’s resignation raises alarms in biotech industrynews2025-04-02T14:51:00+00:00April 2nd, 2025|Chemistry World|
Roche says Ocrevus failed Phase 3 study; Sanofi licenses autoimmune asset from Nurixnews2025-04-02T14:40:03+00:00April 2nd, 2025|Endpoints News|
